Business Context and Reporting Period
Company: The Marcus Corporation (MCS)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: 13 and 26 weeks ended June 27, 2024 (Fiscal Q2 and First Half 2024)
Business Overview: The Company operates two primary segments: Theatres (movie exhibition) and Hotels/Resorts. It also reports Corporate items which include unallocated expenses.
Key Financial Metrics
| Metric (in thousands) | Q2 2024 (13 Weeks) | Q2 2023 (13 Weeks) | YTD 2024 (26 Weeks) | YTD 2023 (26 Weeks) |
|---|---|---|---|---|
| Total Revenues | $176,032 | $207,007 | $314,579 | $359,283 |
| Operating Income (Loss) | $2,237 | $20,810 | $(14,428) | $11,822 |
| Net Earnings (Loss) | $(20,221) | $13,466 | $(32,087) | $4,000 |
| Net Cash from Operating Activities | N/A | N/A | $20,877 | $47,326 |
| Cash and Cash Equivalents | $32,810 | N/A | $32,810 | N/A |
| Total Debt (Net of issuance costs) | $175,677 | N/A | $175,677 | N/A |
| Adjusted EBITDA | $22,000 | $38,700 | $24,300 | $48,200 |
Note: Adjusted EBITDA figures are in millions as presented in the MD&A reconciliation tables.
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 15.0% in Q2 and 12.4% YTD compared to the prior year. The Theatre segment drove this decline with a 25.9% revenue drop in Q2 due to a weaker film slate and lower attendance. Conversely, the Hotels/Resorts segment saw a 6.3% revenue increase in Q2.
- Operating Loss: Operating income collapsed from $20.8 million in Q2 2023 to $2.2 million in Q2 2024. The Theatre segment swung from a $19.8 million operating profit to a $2.8 million profit, while the Hotels segment remained flat at $6.1 million.
- Net Loss: The Company reported a net loss of $20.2 million for Q2 2024, compared to a net profit of $13.5 million in Q2 2023. This was primarily driven by a one-time debt conversion expense of $13.9 million related to the repurchase of convertible senior notes.
- Capital Expenditures: Investing cash outflows increased significantly, with capital expenditures totaling $35.3 million YTD 2024 compared to $15.9 million YTD 2023, largely due to hotel renovations (The Pfister Hotel, Grand Geneva Resort).
Guidance, Outlook, and Management Commentary
- Theatre Outlook: Management expects the quantity of new film releases in Fiscal 2024 to remain negatively impacted by the 2023 labor strikes (WGA/SAG-AFTRA), with many release dates shifting to Fiscal 2025. They anticipate an increased number of films and alternate content events in Fiscal 2025.
- Hotel Outlook: Group room revenue bookings for the remainder of Fiscal 2024 are running approximately 11% ahead of the prior year (excluding the Republican National Convention). Fiscal 2025 group bookings are running over 36% ahead of the prior year pace. Management expects leisure travel to normalize and business travel to gradually increase.
- Tax Rate: The effective income tax rate for Fiscal 2024 is anticipated to be in the 5-10% range, excluding potential legislative changes or valuation allowance adjustments.
- Liquidity: The Company maintains a strong liquidity position with $32.8 million in cash and $175.2 million available under its revolving credit facility. Net leverage is 1.85x.
Risks and Contingencies
- Convertible Note Repurchases: The Company repurchased $86.4 million in aggregate principal amount of Convertible Notes, incurring a $13.9 million expense. Following settlement in July 2024, only $13.6 million of these notes remain outstanding.
- Asset Impairment: A $472,000 impairment charge was recorded for a leased theatre location closed in Q2 2024.
- Joint Venture Guarantees: In connection with the acquisition of The Lofton Hotel (via joint venture), the Company provided a payment guaranty and environmental indemnity with potential liability up to $6.2 million, though cross-indemnity agreements with partners limit net exposure.
- Subsequent Financing: On July 9, 2024, the Company issued $100 million in new Senior Notes (Tranche A and B) to refinance the convertible note repurchases and for general corporate purposes.
Investor Verification Checklist
- Debt Restructuring Impact: Verify the cash flow impact of the $100 million new Senior Notes issuance and the reduction in interest expense from retiring the 5.00% Convertible Notes.
- Film Slate Recovery: Monitor the release schedule for Fiscal 2025 to confirm the anticipated recovery in theatre attendance and revenue following the 2023 strikes.
- Hotel Renovation ROI: Track the performance of the $27 million invested in hotel renovations (The Pfister, Grand Geneva) to ensure RevPAR growth offsets the increased depreciation.
- Covenant Compliance: Confirm continued compliance with the 3.50:1.00 net leverage ratio and 3.00:1.00 interest coverage ratio under the Credit Agreement and new Note Purchase Agreements.
- Share Repurchase Program: Note that 2.4 million shares remain available for repurchase under existing authorizations, though no open market purchases were made in Q2.